Manufacturer
JOINT STOCK COMPANY GRINDEKS(LATVIA)
Registraction Number
MAL24116020AZ
Content:
Grinterol 250 mg hard capsules contain ursodeoxycholic acid 250 mg per capsule.
Indications:
JOINT STOCK COMPANY GRINDEKS(LATVIA)
Registraction Number
MAL24116020AZ
Content:
Grinterol 250 mg hard capsules contain ursodeoxycholic acid 250 mg per capsule.
Indications:
- Dissolution of Cholesterol Gallstones: Treatment of radiolucent (X-ray negative) cholesterol gallstones no larger than 15 mm in diameter in patients with a functioning gallbladder.
- Biliary Reflux Gastritis: Treatment of biliary reflux gastritis.
- Primary Biliary Cirrhosis (PBC): Symptomatic treatment of primary biliary cirrhosis in the absence of decompensated liver cirrhosis.
- Hepatobiliary Disorders in Cystic Fibrosis: Treatment of hepatobiliary disorders in children aged 6 to 18 years with cystic fibrosis.
- Dosage: The dosage is individualized based on the patient's condition and needs. Follow the prescribed regimen closely.
- Administration: Take the capsule orally, with or without food.
- Consistency: Take the medication at the same time each day.
- Monitoring: Regular monitoring by a healthcare provider is essential to ensure effectiveness and adjust dosage if needed.
Inquiry - Grinterol 250 mg hard capsules